The role of P2X7 receptor in prognosis and metastasis of colorectal cancer

被引:50
作者
Zhang, Ying [1 ]
Ding, Jingjing [1 ]
Wang, Lili [1 ]
机构
[1] China Med Univ, Med Res Ctr, Key Lab Res & Applicat Anim Models Environm & Met, Shengiing Hosp, Shenyang 117004, Liaoning, Peoples R China
来源
ADVANCES IN MEDICAL SCIENCES | 2019年 / 64卷 / 02期
基金
中国国家自然科学基金;
关键词
Colorectal cancer; Metastasis; P2X7; receptor; Prognosis; Survival period; CARCINOEMBRYONIC ANTIGEN; TUMOR PROGRESSION; CELL INVASION; METABOLISM; EXPRESSION;
D O I
10.1016/j.advms.2019.05.002
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Purpose: Colorectal cancer (CRC) is one of the leading causes of cancer mortality in the world. P2X7 receptor (P2X7R), encoded by the P2rx7 gene, is a trimeric ion channel activated by extracellular Adenosine triphosphate and is widely expressed in various types of tissues and tumors to regulate inflammation, cell proliferation, or death. The discovery of new biomarkers and understanding the role of P2X7R in CRC are therefore critical to improving the prognosis and treatment of CRC. Materials and methods: P2X7R expression was analyzed in CRC tumor samples and normal colorectal tissues from 97 patients and various colon cancer cell lines. The correlation of tumor antigens, survival periods, and P2X7R expression were documented. Results: P2X7R(High )and P2X7R(Low )populations were observed in CRC patients. P2X7R(High ) patients had relatively shorter survival periods, higher levels of serum carcinoembryonic antigen, and greater numbers of advanced tumors. In addition, P2X7R expression had a significant up-regulation in metastatic CRC and metastatic CRC cell lines, which indicates that P2X7R expression is positively associated with metastasis. Conclusions: P2X7R expression might be a potential biomarker for prognosis and metastasis of CRC.
引用
收藏
页码:388 / 394
页数:7
相关论文
共 29 条
[1]   Expression of P2X7 Receptor Increases In Vivo Tumor Growth [J].
Adinolfi, Elena ;
Raffaghello, Lizzia ;
Giuliani, Anna Lisa ;
Cavazzini, Luigi ;
Capece, Marina ;
Chiozzi, Paola ;
Bianchi, Giovanna ;
Kroemer, Guido ;
Pistoia, Vito ;
Di Virgilio, Francesco .
CANCER RESEARCH, 2012, 72 (12) :2957-2969
[2]   The P2X7 receptor is a key modulator of aerobic glycolysis [J].
Amoroso, F. ;
Falzoni, S. ;
Adinolfi, E. ;
Ferrari, D. ;
Di Virgilio, F. .
CELL DEATH & DISEASE, 2012, 3 :e370-e370
[3]   Stalling the Engine of Resistance: Targeting Cancer Metabolism to Overcome Therapeutic Resistance [J].
Butler, Ethan B. ;
Zhao, Yuhua ;
Munoz-Pinedo, Cristina ;
Lu, Jianrong ;
Tan, Ming .
CANCER RESEARCH, 2013, 73 (09) :2709-2717
[4]   Colorectal cancer drugs market [J].
Cassidy, Sorcha ;
Syed, Basharut A. .
NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (08) :525-526
[5]   Cancer metabolism: The Warburg effect today [J].
Ferreira, Leonardo M. R. .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2010, 89 (03) :372-380
[6]   Targeting of the P2X7 receptor in pancreatic cancer and stellate cells [J].
Giannuzzo, Andrea ;
Saccomano, Mara ;
Napp, Joanna ;
Ellegaard, Maria ;
Alves, Frauke ;
Novak, Ivana .
INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (11) :2540-2552
[7]   The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells [J].
Giannuzzo, Andrea ;
Pedersen, Stine Falsig ;
Novak, Ivana .
MOLECULAR CANCER, 2015, 14
[8]   New Aspects of an Old Drug - Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells [J].
Gottfried, Eva ;
Lang, Sven A. ;
Renner, Kathrin ;
Bosserhoff, Anja ;
Gronwald, Wolfram ;
Rehli, Michael ;
Einhell, Sabine ;
Gedig, Isabel ;
Singer, Katrin ;
Seilbeck, Anton ;
Mackensen, Andreas ;
Grauer, Oliver ;
Hau, Peter ;
Dettmer, Katja ;
Andreesen, Reinhard ;
Oefner, Peter J. ;
Kreutz, Marina .
PLOS ONE, 2013, 8 (07)
[9]  
Hewitt RE, 2000, J PATHOL, V192, P446
[10]   Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].
Hurwitz, H ;
Fehrenbacher, L ;
Novotny, W ;
Cartwright, T ;
Hainsworth, J ;
Heim, W ;
Berlin, J ;
Baron, A ;
Griffing, S ;
Holmgren, E ;
Ferrara, N ;
Fyfe, G ;
Rogers, B ;
Ross, R ;
Kabbinavar, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342